These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9759628)

  • 1. Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptor on platelets.
    Lévy-Toledano S; Maclouf J; Rosa JP; Gallet C; Vallès G; Nurden P; Nurden AT
    Thromb Haemost; 1998 Sep; 80(3):463-8. PubMed ID: 9759628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
    Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
    Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
    Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
    Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
    Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
    Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin modulates platelet activation in vitro through protein-tyrosine phosphorylation.
    Kubota Y; Arai T; Tanaka T; Yamaoka G; Kiuchi H; Kajikawa T; Kawanishi K; Ohnishi H; Yamaguchi M; Takahara J; Irino S
    Stem Cells; 1996 Jul; 14(4):439-44. PubMed ID: 8843545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
    Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets possess functional TGF-beta receptors and Smad2 protein.
    Lev PR; Salim JP; Marta RF; Osorio MJ; Goette NP; Molinas FC
    Platelets; 2007 Feb; 18(1):35-42. PubMed ID: 17365852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
    Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
    Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient tyrosine phosphorylation of proteins after activation of platelets with thrombin depends on intact glycoprotein Ib.
    Diaz-Ricart M; Fuste B; Estebanell E; Tonda R; Lozano M; Escolar G; Jamieson G; Ordinas A
    Platelets; 2005 Dec; 16(8):453-61. PubMed ID: 16287612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphotyrosine proteins in platelets from patients with storage pool disease: direct relation between granule defects and defective signal transduction.
    Arderiu G; Díaz-Ricart M; Domenech P; Escolar G; Ordinas A; Pujol-Moix N
    Haematologica; 2002 Jun; 87(6):629-36. PubMed ID: 12031920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
    Rozalski M; Nocun M; Watala C
    Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.
    Pearce AC; Wonerow P; Marshall SJ; Frampton J; Gartner TK; Watson SP
    Biochem J; 2004 Feb; 378(Pt 1):193-9. PubMed ID: 14558887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new role for FcgammaRIIA in the potentiation of human platelet activation induced by weak stimulation.
    Canobbio I; Stefanini L; Guidetti GF; Balduini C; Torti M
    Cell Signal; 2006 Jun; 18(6):861-70. PubMed ID: 16169188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of postaggregation events induced by protease-activated receptor 1 ligation in human platelets: evidence of differential signaling pathways.
    Ramars AS; Mukhopadhyay S; Dash D
    Arch Biochem Biophys; 2002 Feb; 398(2):253-60. PubMed ID: 11831857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling.
    Schweigel H; Geiger J; Beck F; Buhs S; Gerull H; Walter U; Sickmann A; Nollau P
    Proteomics; 2013 Mar; 13(6):1016-27. PubMed ID: 23322602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.
    Jarvis GE; Atkinson BT; Snell DC; Watson SP
    Br J Pharmacol; 2002 Sep; 137(1):107-17. PubMed ID: 12183336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of platelet activation in vitro by thrombopoietin.
    Kojima H; Hamazaki Y; Nagata Y; Todokoro K; Nagasawa T; Abe T
    Thromb Haemost; 1995 Dec; 74(6):1541-5. PubMed ID: 8772234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.
    Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K
    Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.